Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.
Stay updated with breaking news from Call Transcript March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc.
Medicine Man Technologies, Inc. misses on earnings expectations. Reported EPS is $-0.43 EPS, expectations were $-0.13. Medicine Man Technologies, Inc.
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this time all participants are in a listen-only mode.
Helius Medical Technologies, Inc. beats earnings expectations. Reported EPS is $-1.47, expectations were $-4.05.